We have a lot of news to share with you! Join us in a virtual Town Hall on January 22 to hear all about the...
Don’t miss out on GivingTuesday! What a great opportunity to show your support to the CHS. bit.ly/DonateToCHS
Readers of the Canadian Hemophilia Society (CHS) annual reports may have observed references emphasizing the significance of HealthPartners to the CHS. But what exactly is...
Two distinct fellowships will be offered by the CHS to allow community members to attend the upcoming World Federation of Hemophilia World Congress taking place...
Drawing on over fifty years of experience, DR. ROBERT T. CARD and DR. MAN-CHIU POON combine first-hand insights with interviews from more than seventy health care...
Almost two years ago, a national study was launched to better understand chronic pain among people living with HIV in Canada. Co-led by five peer-researchers,...
MONTREAL, October 7, 2025 – CSL Behring Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) have announced signing of a Letter of Intent that sets pricing...
MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for...
While this does not affect Canada directly, it is a major step forward for the international community and acknowledges what Canada is already doing in...
The call for applications for the CHS’ research programs for the 2026-2027 grant period is ongoing. The deadline to submit applications for all the programs...
The CHS educational catalogue has been updated. CLICK HERE to take a look at its dynamic online version or to download it as a PDF.
MONTRÉAL, July 3, 2025 – In June, both Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS) released...
Montréal, July 1, 2025 – On this very special 2025 Canada Day, the CHS could not be prouder as, yesterday, Kathy Mulder, a long-acting volunteer...
The CHS is very proud to present its latest publication, the first component of its brand-new Novel Therapies Education Program. CLICK HERE to access the online booklet.